Transforming Growth Factor-β2 Downregulates Major Histocompatibility Complex (MHC) I and MHC II Surface Expression on Equine Bone Marrow-Derived Mesenchymal Stem Cells Without Altering Other Phenotypic Cell Surface Markers

Allogeneic mesenchymal stem cells (MSCs) are a promising cell source for treating musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered, however, by recipient immune recognition and rejection of major histocompatibility complex (MHC)-mismatched MSCs. Development o...

Descripción completa

Detalles Bibliográficos
Autores principales: Berglund, Alix K., Fisher, Matthew B., Cameron, Kristin A., Poole, Emma J., Schnabel, Lauren V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Veterinary Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466990/
https://www.ncbi.nlm.nih.gov/pubmed/28660198
http://dx.doi.org/10.3389/fvets.2017.00084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466990/
https://www.ncbi.nlm.nih.gov/pubmed/28660198
http://dx.doi.org/10.3389/fvets.2017.00084

Ejemplares similares